(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2025-10-13 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 965311
Date | Daily Closing Price | Open | High | Low | Volume |
13 Mon Oct 2025 | 4.28 | 4.15 | 4.30 | 4.10 | 0.742 times |
10 Fri Oct 2025 | 4.11 | 4.27 | 4.30 | 4.10 | 0.786 times |
09 Thu Oct 2025 | 4.27 | 4.15 | 4.31 | 4.10 | 1.264 times |
08 Wed Oct 2025 | 4.18 | 4.31 | 4.39 | 4.17 | 0.779 times |
07 Tue Oct 2025 | 4.29 | 4.37 | 4.54 | 4.28 | 1.136 times |
06 Mon Oct 2025 | 4.34 | 4.39 | 4.40 | 4.29 | 0.944 times |
03 Fri Oct 2025 | 4.38 | 4.52 | 4.53 | 4.30 | 0.924 times |
02 Thu Oct 2025 | 4.49 | 4.59 | 4.60 | 4.38 | 0.634 times |
01 Wed Oct 2025 | 4.59 | 4.55 | 4.66 | 4.53 | 1.363 times |
30 Tue Sep 2025 | 4.54 | 4.44 | 4.55 | 4.40 | 1.29 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 4.3, but if it comes above 4.3, then a intra day buy could be more profitable.
If you take a sell trade below 4.3, then use 4.3 as stoploss and 4.1 as target. However if you take a buy trade in stock , then use 4.3 as stoploss and 4.38 as target.
Share price targets for Arbutus Biopharma (ABUS)
Target Type | Value |
Downside Target | 3.04 |
Downside Target | 3.27 |
Downside Target | 3.42 |
Downside Target | 3.62 |
Downside Target | 4.10 |
Upside Target | 4.30 |
Upside Target | 4.54 |
Upside Target | 4.56 |
Upside Target | 4.57 |
Upside Target | 4.66 |
Upside Target | 5.10 |
Intraday share price targets for Arbutus Biopharma (ABUS)
Target Type | Value |
Downside Intraday Target | 4.15 |
Downside Intraday Target | 4.03 |
Upside Intraday Target | 4.35 |
Upside Intraday Target | 4.43 |
Downside Intraday Target | 4.23 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
Date | Weekly Closing Price | Open | High | Low | Volume |
13 Mon Oct 2025 | 4.28 | 4.15 | 4.30 | 4.10 | 0.151 times |
10 Fri Oct 2025 | 4.11 | 4.39 | 4.54 | 4.10 | 0.964 times |
03 Fri Oct 2025 | 4.38 | 4.47 | 4.66 | 4.30 | 1.158 times |
26 Fri Sep 2025 | 4.41 | 4.25 | 4.56 | 4.25 | 0.668 times |
19 Fri Sep 2025 | 4.25 | 4.50 | 4.57 | 4.18 | 0.482 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
Date | Monthly Closing Price | Open | High | Low | Volume |
13 Mon Oct 2025 | 4.28 | 4.55 | 4.66 | 4.10 | 0.247 times |
30 Tue Sep 2025 | 4.54 | 3.69 | 5.10 | 3.66 | 1.917 times |
29 Fri Aug 2025 | 3.71 | 3.27 | 3.73 | 3.27 | 1.173 times |
31 Thu Jul 2025 | 3.28 | 3.07 | 3.42 | 3.06 | 0.953 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term but the sell signal is initial and weak.
Arbutus Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.36 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term but the sell signal is initial and weak.
Arbutus Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.36 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.